Delaware Court Consolidates, Postpones Trial In Adderall XR Patent Challenge
A Delaware federal court has postponed the trial in Impax Laboratories, Inc.'s patent challenge against Shire Pharmaceuticals Group's best-selling attention-deficit-disorder treatment Adderall XR until February 2006....To view the full article, register now.
Already a subscriber? Click here to view full article